Ideaz optimized the device for low volume production


We started with a mechanical layout from our client and made some simple but meaningful modifications to ensure the configuration was suitable for a low volume casing process that eliminated the need for injection molded tooling costs and lead times.


Shortly after the device made its public debut, CyVek was purchased by BioTechne for $60 million in cash—with up to $195 million once milestones were met. Working closely with the engineers at CyVek and focusing on user needs, Ideaz was able to help CyVek achieve rapid commercial success and a great ROI.

Let's connect